March 29, 2001Mislabeled Cancer Drug Recalled
Wholesalers, hospital pharmacists, and oncology healthcare professionals.
Germany (SafetyAlerts) - Aventis
Pharmaceuticals has initiated a voluntary recall of Taxotere® (docetaxel) for Injection
Concentrate 20-mg active and diluent vials. It has been determined that the Taxotere
20mg vial containing the active ingredient may have inadvertently been labeled as a
diluent vial. Aventis has received one product complaint related to this mislabeling.
The lot numbers for this recall are:
0P273 (active) which was packaged together with diluent vials with the following lot
numbers: 0T446 (diluent) or 0T449 (diluent).
More information is available in the letter to healthcare professionals.
comprehensive safety recall information for the United States. SafetyAlerts Newsletter is a free email service to warn
consumers of faulty products and contaminated foods. For complete information regarding
current recalls, past recalls and timely product warning notification visit: www.safetyalerts.com.